These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2865694)

  • 1. The discriminant dopamine antagonist property of benzamides is observed at various times after their systemic or intracerebroventricular administration.
    Protais P; Hermier C; Costentin J
    Neuropharmacology; 1985 Sep; 24(9):861-7. PubMed ID: 2865694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
    Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
    J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unexpected potentiation by discriminant benzamide derivatives of stereotyped behaviours elicited by dopamine agonists in mice.
    Vasse M; Protais P; Costentin J; Schwartz JC
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Apr; 329(2):108-16. PubMed ID: 4040215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of apomorphine-induced stereotyped behaviour by acute treatment with dopamine depleting agents: a potential role for an increased stimulation of D1 dopamine receptors.
    Vasse M; Protais P
    Neuropharmacology; 1989 Sep; 28(9):931-9. PubMed ID: 2554186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of dopamine antagonists discriminating various behavioral responses and radioligand binding sites.
    Martres MP; Sokoloff P; Delandre M; Schwartz JC; Protais P; Costentin J
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Feb; 325(2):102-15. PubMed ID: 6144046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characteristics of dopamine receptors involved in the dual effect of dopamine agonists on yawning behaviour in rats.
    Protais P; Dubuc I; Costentin J
    Eur J Pharmacol; 1983 Oct; 94(3-4):271-80. PubMed ID: 6140175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous catalepsy and apomorphine-induced stereotypic behavior in mice.
    Yurek DM; Randall PK
    Life Sci; 1985 Nov; 37(18):1665-73. PubMed ID: 4058245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of (-)-sulpiride and YM-09151-2 on stereotyped behavior in chicks and catalepsy in rats.
    Wambebe C
    Jpn J Pharmacol; 1987 Feb; 43(2):121-8. PubMed ID: 2883335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipsychotic substances and dopamine in the rat brain; behavioral studies reveal distinct dopamine receptor systems.
    Van Ree JM; Elands J; Király I; Wolterink G
    Eur J Pharmacol; 1989 Aug; 166(3):441-52. PubMed ID: 2572429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotic-like vs cataleptogenic actions in mice of novel antipsychotics having D2 antagonist and 5-HT1A agonist properties.
    Bardin L; Kleven MS; Barret-Grévoz C; Depoortère R; Newman-Tancredi A
    Neuropsychopharmacology; 2006 Sep; 31(9):1869-79. PubMed ID: 16237379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased grooming behaviour is induced by apomorphine in mice treated with discriminant benzamide derivatives.
    Vasse M; Protais P
    Eur J Pharmacol; 1988 Oct; 156(1):1-11. PubMed ID: 2905270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of the dopamine antagonist remoxipride on apomorphine induced behaviour in the rat.
    Ståhle L; Ljungberg T; Rodebjer A; Ogren SO; Ungerstedt U
    Pharmacol Toxicol; 1987 Mar; 60(3):227-32. PubMed ID: 2884654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antistereotypic effects of dopamine D-1 and D-2 antagonists after intrastriatal injection in rats. Pharmacological and regional specificity.
    Arnt J
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Aug; 330(2):97-104. PubMed ID: 2864641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Behavioral effects of chronic apomorphine, and D-1/D-2 dopamine receptor activities in rats].
    Minematsu N
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Jun; 15(3):247-52. PubMed ID: 7584718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical neuroleptic-like behavioral effects of neurotensin.
    Jolicoeur FB; Gagné MA; Rivest R; Drumheller A; St-Pierre S
    Brain Res Bull; 1993; 32(5):487-91. PubMed ID: 8106129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzamides and classical neuroleptics: comparison of their actions using 6 apomorphine-induced effects.
    Puech AJ; Simon P; Boissier JR
    Eur J Pharmacol; 1978 Aug; 50(4):291-300. PubMed ID: 29758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine receptor antagonist properties of S 14506, 8-OH-DPAT, raclopride and clozapine in rodents.
    Protais P; Chagraoui A; Arbaoui J; Mocaër E
    Eur J Pharmacol; 1994 Dec; 271(1):167-77. PubMed ID: 7698199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of sigma(1) receptor ligand MS-377 on D(2) antagonists-induced behaviors.
    Karasawa J; Takahashi S; Takagi K; Horikomi K
    Pharmacol Biochem Behav; 2002 Oct; 73(3):505-10. PubMed ID: 12151023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotensin selectively antagonizes apomorphine-induced stereotyped climbing.
    Jolicoeur FB; Gagne MA; Rivest R; Drumheller A; St-Pierre S
    Pharmacol Biochem Behav; 1991 Feb; 38(2):463-5. PubMed ID: 2057514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity.
    Schoemaker H; Claustre Y; Fage D; Rouquier L; Chergui K; Curet O; Oblin A; Gonon F; Carter C; Benavides J; Scatton B
    J Pharmacol Exp Ther; 1997 Jan; 280(1):83-97. PubMed ID: 8996185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.